Brand Name: CLOPIDOGREL-B
Generic Name: Clopidogrel Bisulfate Tablets USP
Available Strengths:
75mg/150mg
Clopidogrel Bisulfate Tablets USP are a trusted antiplatelet therapy designed to reduce the risk of clot formation in patients with recent myocardial infarction, stroke, or established peripheral arterial disease. By inhibiting platelet aggregation, Clopidogrel helps maintain smooth blood flow, preventing dangerous clots that may lead to serious cardiovascular complications. Manufactured under strict USP quality standards, these tablets offer high purity, reliable bioavailability, and consistent clinical effectiveness. Ideal for global healthcare providers, Clopidogrel Bisulfate supports long-term cardiovascular management and improves patient outcomes across diverse cardiac conditions.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com